Issue 2/1997
Content (11 Articles)
Pre-clinical activity of taxol in non-seminomatous germ cell tumor cell lines and nude mouse xenografts
T.A. Dunn, H.J. Schmoll, V. Grüunwald, J. Casper, C. Bokemeyer
Treatment of human prostate tumors PC-3 and TSU-PR1 with standard and investigational agents in SCID mice
Lisa Polin, Frederick Valeriote, Kathryn White, Chiab Panchapor, Susan Pugh, Juiwanna Knight, Patricia LoRusso, Maha Hussain, Elaine Liversidge, Nancy Peltier, Trimurtulu Golakoti, Gregory Patterson, Richard Moore, Thomas H. Corbett
Comparative cytotoxicity of oxaliplatin and cisplatin in non-seminomatous germ cell cancer cell lines
T.A. Dunn, H.J. Schmoll, V. Grünwald, V. Bokemeyer, J. Casper
Prolonged infusion gemcitabine: a clinical phase I study at low- (300 mg/m2) and high-dose (875 mg/m2) levels
Camillo F. Pollera, Anna Ceribelli, Marcello Crecco, Cristina Oliva
Phase I trial of Uracil-Tegafur (UFT) plus oral leucovorin: 14-day schedule
Richard Pazdur, Yvonne Lassere, Enrique Diaz-Canton, Beth Bready, Dah H. Ho
Phase I study of paclitaxel on a 3-hour schedule followed by carboplatin in untreated patients with stage IV non-small cell lung cancer
Eric K. Rowinsky, William A. Flood, Susan E. Sartorius, Kathy M. Bowling, David S. Ettinger
Phase I trial of fluorouracil modulation by n-phosphonacetyl-l-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer
Alexandre Hageboutros, Gary R. Hudes, Fran Greene, Frank P. LaCreta, James Brennan, Peter J. O'Dwyer
Early clinical investigaiton of sulofenur with a daily schedule in advanced solid tumours
Anders Krarup-Hansen, Hans Pedersen, Elo Andersen, Helle Andersen, Heine H. Hansen
A phase II trial of intravenous vinorelbine in previously untreated patients with extensive small cell lung cancer, a southwest oncology group study
Celestia S. Higano, John J. Crowley, Robert V. Veith, Robert B. Livingston
Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladder
Masoud Khorsand, Joan Lange, Lynn Feun, Neil J. Clendeninn, Mary Collier, George Wilding
An ECOG Phase II Study of Amonafide in Unresectable or Recurrent Carcinoma of the Head and Neck (PB390)
Andrea N. Leaf, Donna Neuberg, Edward L. Schwartz, Scott Wadler, Paul S. Ritch, Janice P. Dutcher, George L. Adams